Body Handbook Catalogue Profile Ranking
Supplements BODY HANDBOOK
Supplements Β· Β§484
Acetyl-L-Carnitine (ALCAR)
The supplement aisle sells acetyl-L-carnitine as a nootropic for a sharp brain that wants to be sharper. That's the one thing it doesn't do. It gives back what you've been losing, so a healthy young person feels nothing. But three groups running low get real value for the cost of two coffees a month: late-midlife memory slip, depression the antidepressant only half-fixed, and diabetic nerve pain, where it's one of the rare things that regrew the nerve instead of muting the signal.
Do Β· Daily Evidence Emerging Chapter Supplements

Acetyl-L-carnitine is the carnitine in red meat with an acetyl group added β€” the change that lets it cross into the brain, which plain L-carnitine can't do at oral doses. That's why the mood and memory evidence is for the acetyl form specifically and doesn't transfer to the L-carnitine sitting next to it on the shelf.

Memory: in mild cognitive impairment and early Alzheimer's, it slows decline on memory and attention tests by a small, consistent margin, showing by three months 1. It's small enough that reviewers split on whether it's worth using 2.

Depression: it matched fluoxetine and amisulpride on mood with far fewer gut, sleep, and sexual side effects, and worked best in older and treatment-resistant patients 3 β€” the same people whose blood levels of it run low to start 4.

Diabetic nerve pain: a year on 3 g a day cut pain and left more living nerve fibres in a calf biopsy than at the start 5. Gabapentin and duloxetine mute the signal; this touched the nerve itself.

Match the dose to why you're taking it, and give it months.

The felt change is modest and specific. In depression it's the floor coming up: bad mornings less bad, and the side-effect tax of the SSRI easing. In memory it's slope-softening β€” the crossword you finished last year is one you can still finish. In neuropathy the burning eases from nightly to occasional, and the biopsy shows real nerve underneath. If you weren't in any of the three groups, you take it three months, feel the same, and are out about thirty dollars.

The fine print β€” when to skip it, and what people get wrong

Skip it during taxane chemo (paclitaxel, docetaxel): given to prevent nerve damage, it made it worse at both six months and a year 6. If your thyroid is underactive and not fully replaced, carnitine blunts thyroid action and can drag you further into it β€” check labs first 7. With existing heart disease, gut bacteria turn carnitine into TMAO, linked to atherosclerosis; stay low-dose and ask the cardiologist 8.

It's a nootropic: no β€” nearly every positive cognitive trial enrolled people with mild impairment, never healthy young brains. Carnitine fixes neuropathy, full stop: it helped diabetic nerves and harmed nerves during chemo, so treat it as specific, not a general repair agent. More is better: the dose plateaus, and the long-term heart question grows with duration; most of the upside sits between 1 and 2 g.

References
  1. 1Montgomery SA, Thal LJ, Amenta F (2003). Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. International Clinical Psychopharmacology. link
  2. 2Hudson S, Tabet N (2003). Acetyl-l-carnitine for dementia. Cochrane Database of Systematic Reviews. link
  3. 3Veronese N, Stubbs B, Solmi M, Ajnakina O, Carvalho AF, Maggi S (2018). Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis. Psychosomatic Medicine. link
  4. 4Nasca C, Bigio B, Lee FS, Young SP, Kautz MM, Albright A, Beasley J, Millington DS, MathΓ© AA, Kocsis JH, Murrough JW, McEwen BS, Rasgon N (2018). Acetyl-l-carnitine deficiency in patients with major depressive disorder. Proceedings of the National Academy of Sciences. link
  5. 5Sima AAF, Calvani M, Mehra M, Amato A (2005). Acetyl-L-Carnitine Improves Pain, Nerve Regeneration, and Vibratory Perception in Patients With Chronic Diabetic Neuropathy: An analysis of two randomized placebo-controlled trials. Diabetes Care. link
  6. 6Hershman DL, Unger JM, Crew KD, Minasian LM, Awad D, Moinpour CM, Hansen L, Lew DL, Greenlee H, Fehrenbacher L, Wade JL 3rd, Wong SF, Hortobagyi GN, Meyskens FL, Albain KS (2013). Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. Journal of Clinical Oncology. link
  7. 7Benvenga S (2008). Effects of L-carnitine on thyroid hormone metabolism and on physical exercise tolerance. Hormone and Metabolic Research. link
  8. 8Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WHW, Bushman FD, Lusis AJ, Hazen SL (2013). Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nature Medicine. link
Β·
484